Literature DB >> 15307695

[Preliminary exploration on effect of qilian decoction in intervention treatment of diabetes mellitus type 2 with insulin resistance and its influence on related inflammatory cytokines].

Shu-rong Gao1, Jian-hong Bu, Liang-zheng Zhu.   

Abstract

OBJECTIVE: To observe the synergistic effect of Qilian decoction (QLD) with corresponding hypoglycemic agents on insulin sensitivity in patients with diabetes mellitus type 2 and its influence on related inflammatory cytokines.
METHODS: Sixty-two patients with diabetes mellitus type 2 were selected and randomly divided into two groups, they were treated with hypoglycemic agent in routine, and QLD was given orally, one dose taken in twice a day. Parameters as fasting blood glucose, insulin, peptide C, tumor necrosis factor-alpha (TNF-alpha), C-reactive protein (CRP), interleukin 6 (IL-6) were measured before and after treatment, and insulin sensitive index (ISI) was also calculated.
RESULTS: The level of fasting blood glucose lowered after treatment in both groups (P<0.01); levels of fasting insulin, peptide C, ISI, TNF-alpha, IL-6 and CRP significantly lowered after treatment (P<0.05 or P<0.01), and the effect was better than that in the control group (P<0.05 or P<0.01).
CONCLUSION: QLD could improve the insulin resistance and lower the levels of related inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15307695

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  1 in total

1.  Qingre Yiqi Method along with Oral Hypoglycemic Drugs in Treating Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Li Jiang; Shidong Wang; Jinxi Zhao; Weijun Huang; Jiayue Li; Yonghua Xiao; Hua Zhang; Qiang Fu; Yu Chen; Tao Yang; Esther Aijia Shen; Guanxun Su; Yaofu Zhang; Zhuang Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-11       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.